Freshpet Raises 2026 Guidance on Strong Q2, but Shares Dip on Valuation Fears

What happened

Freshpet reported Q2 2026 results that topped consensus estimates and raised full-year revenue guidance to $1.21–$1.23 billion and EBITDA to $210–$220 million, driven by expanding fridge count, digital channel momentum, and new packaging technology. Despite the beat, the stock fell 6.6% as the market focused on the premium valuation already embedded in the share price. Operational execution remains robust, with market share rising to 4.3% in dog food and treats, but competitive pressure from Blue Buffalo’s fresh rollout looms larger. The updated guidance aligns closely with our earlier bull case, yet the negative price reaction suggests investors see limited upside at current multiples. We maintain our wait-and-see posture, looking for stronger evidence of durable competitive advantage before upgrading the thesis.

Implication

Freshpet’s Q2 beat and raised 2026 guidance reinforce the bull case of low-teens growth and margin progress, yet the 6.6% post-earnings drop underscores market skepticism about the premium valuation. With EBITDA guidance pointing to ~18% margins, the stock may already price in much of the good news, especially as Blue Buffalo’s fresh line gains traction. Investors should hold if already positioned, but avoid adding unless the stock approaches attractive entry levels near $60, as per our base-case implied value of $80. The thesis remains intact but requires continued monitoring of competitive encroachment and fridge expansion. For now, the risk/reward is balanced, favoring patience.

Thesis delta

The strong Q2 results and raised guidance tilt the outlook toward the bull case, with revenue growth now expected near 14% and EBITDA margins on track. However, the market’s negative reaction reinforces the WAIT rating; the stock may have overshot near-term fair value, and competitive risks keep the reward-to-risk unattractive for new money. The entry target remains $60, and trim remains above $95 if the stock rallies on excessive optimism.